iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors
April 22, 2024
April 22, 2024
ST. LOUIS PARK, Minnesota, April 22 [Category: Medical] -- Medical Alley posted the following news release:
MINNEAPOLIS, April 22, 2024 /PRNewswire/ -- iVEAcare, a privately held, development stage medical device company, announced the close of a $27.5 million Series A financing. The financing was led by Vensana Capital, which was joined by Treo Ventures, Hatteras Venture Partners, and an undisclosed strategic partner. iVEAcare is the third spin-off from NuXcel, a medical device acc . . .
MINNEAPOLIS, April 22, 2024 /PRNewswire/ -- iVEAcare, a privately held, development stage medical device company, announced the close of a $27.5 million Series A financing. The financing was led by Vensana Capital, which was joined by Treo Ventures, Hatteras Venture Partners, and an undisclosed strategic partner. iVEAcare is the third spin-off from NuXcel, a medical device acc . . .